Pang; Iok-Hou

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pang; Iok-Hou.The latest application filed is for "use of salidroside and derivative thereof in preparation of inhibitor medicament for diseases of ophthalmic fibrosis caused by abnormalities of extracellular matrix proteins".

Company Profile

0.15.44

Pang; Iok-Hou - Shanghai CN
Pang; Iok-Hou - Grand Prairie TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Salidroside And Derivative Thereof In Preparation Of Inhibitor Medicament For Diseases Of Ophthalmic Fibrosis Caused By Abnormalities Of Extracellular Matrix Proteins App 20210260091 - GUO; Tao ; et al.	2021-08-26
Methods Of Treating Ophthalmic Diseases Using Npr-b Agonists App 20180094029 - Hellberg; Mark R. ; et al.	2018-04-05
Methods of treating ophthalmic diseases using NPR-B agonists Grant 9,822,147 - Hellberg , et al. November 21, 2	2017-11-21
Composition Of Lipid-based Nanoparticles For Small Molecules And Macromolecules App 20170165200 - DONG; Xiaowei ; et al.	2017-06-15
Methods Of Treating Ophthalmic Diseases Using Npr-b Agonists App 20170101440 - Hellberg; Mark R. ; et al.	2017-04-13
Methods of treating ophthalmic diseases using NPR-B agonists Grant 9,187,525 - Hellberg , et al. November 17, 2	2015-11-17
Novel Npr-b Agonists App 20130345136 - Hellberg; Mark R. ; et al.	2013-12-26
NPR-B agonists Grant 8,551,938 - Hellberg , et al. October 8, 2	2013-10-08
Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma App 20120283260 - Combrink; Keith D. ; et al.	2012-11-08
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma Grant 8,252,793 - Combrink , et al. August 28, 2	2012-08-28
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20120115870 - Fleenor; Debra L. ; et al.	2012-05-10
Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma App 20120046285 - Combrink; Keith D. ; et al.	2012-02-23
Use Of Inhibitors Of Jun N-terminal Kinases To Treat Glaucoma App 20120004274 - Fleenor; Debra L. ; et al.	2012-01-05
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20110160210 - Fleenor; Debra L. ; et al.	2011-06-30
Agents For Treatment Of Glaucomatous Retinopathy And Optic Neuropathy App 20110144127 - Landers; Robert A. ; et al.	2011-06-16
Novel Npr-b Agonists App 20110112038 - Hellberg; Mark R. ; et al.	2011-05-12
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders App 20110105574 - Fleenor; Debra L. ; et al.	2011-05-05
Statins For The Treatment Of Ocular Hypertension And Glaucoma App 20110098314 - Hellberg; Mark R. ; et al.	2011-04-28
Agents Which Regulate, Inhibit, Or Modulate The Activity And/or Expression Of Connective Tissue Growth Factor (ctgf) As A Unique Means To Both Lower Intraocular Pressure And Treat Glaucomatous Retinopathies/optic Neuropathies App 20110092523 - Fleenor; Debra L. ; et al.	2011-04-21
RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS App 20110028534 - Shepard; Allan R. ; et al.	2011-02-03
Use Of Inhibitors Of Jun N-terminal Kinases To Treat Glaucoma App 20100311716 - Fleenor; Debra L. ; et al.	2010-12-09
RNAi inhibition of CTGF for treatment of ocular disorders Grant 7,838,507 - Shepard , et al. November 23, 2	2010-11-23
Use Of Inhibitors Of Jun N-terminal Kinases For The Treatment Of Glaucomatous Retinopathy And Ocular Diseases App 20100280089 - Pang; Iok-Hou ; et al.	2010-11-04
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders App 20100260784 - Fleenor; Debra L. ; et al.	2010-10-14
Use of inhibitors of Jun N-terminal kinases to treat glaucoma Grant 7,803,824 - Fleenor , et al. September 28, 2	2010-09-28
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders App 20100183629 - Fleenor; Debra L. ; et al.	2010-07-22
RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS App 20100035969 - Shepard; Allan R. ; et al.	2010-02-11
Inhibitors Of Glycogen Synthase Kinase-3 (gsk-3) For Treating Glaucoma App 20090312390 - Hellberg; Mark R. ; et al.	2009-12-17
Method of treating glaucoma Grant 7,625,927 - Klimko , et al. December 1, 2	2009-12-01
RNAi inhibition of CTGF for treatment of ocular disorders Grant 7,622,454 - Shepard , et al. November 24, 2	2009-11-24
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma Grant 7,598,288 - Hellberg , et al. October 6, 2	2009-10-06
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders App 20090202524 - Fleenor; Debra L. ; et al.	2009-08-13
Use of non-feminizing estrogens as treatment for retinal vascular diseases Grant 7,488,723 - Pang February 10, 2	2009-02-10
Agents Which Regulate, Inhibit, Or Modulate The Activity And/or Expression Of Connective Tissue Growth Factor (ctgf) As A Unique Means To Both Lower Intraocular Pressure And Treat Glaucomatous Retinopathies/optic Neuropathies App 20080176964 - Fleenor; Debra L. ; et al.	2008-07-24
Inhibitors Of Protein Kinase C-delta For The Treatment Of Glaucoma App 20080153903 - FLEENOR; Debra L. ; et al.	2008-06-26
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma Grant 7,384,926 - Pang , et al. June 10, 2	2008-06-10
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders App 20080107644 - FLEENOR; Debra L. ; et al.	2008-05-08
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies Grant 7,351,407 - Fleenor , et al. April 1, 2	2008-04-01
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders App 20080025973 - FLEENOR; Debra L. ; et al.	2008-01-31
Use Of Non-feminizing Estrogens As Retinoprotective Agents For The Treatment Of Glaucoma App 20070225263 - Pang; Iok-Hou ; et al.	2007-09-27
Method Of Treating Glaucoma App 20070203174 - KLIMKO; Peter G. ; et al.	2007-08-30
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20070142376 - FLEENOR; Debra L. ; et al.	2007-06-21
Use of inhibitors of Jun N-terminal kinases to treat glaucoma App 20060172991 - Fleenor; Debra L. ; et al.	2006-08-03
RNAi inhibition of CTGF for treatment of ocular disorders App 20060166919 - Shepard; Allan R. ; et al.	2006-07-27
Use of AP-1 activators to treat glaucoma and ocular hypertension App 20060142379 - Shade; Debra L. ; et al.	2006-06-29
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases App 20060094753 - Pang; Iok-Hou ; et al.	2006-05-04
Neurophilin ligands for treating ocular conditions App 20060083774 - Pang; Iok-Hou ; et al.	2006-04-20
Use of AP-1 activators to treat glaucoma and ocular hypertension Grant 7,005,446 - Shade , et al. February 28, 2	2006-02-28
Statins for the treatment of ocular hypertension and glaucoma App 20050239871 - Hellberg, Mark R. ; et al.	2005-10-27
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies App 20050234075 - Fleenor, Debra L. ; et al.	2005-10-20
Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases App 20050203121 - Pang, Iok-hou	2005-09-15
Agents for treatment of glaucomatous retinopathy and optic neuropathy App 20050137146 - Landers, Robert A. ; et al.	2005-06-23
Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases Grant 6,906,077 - Pang June 14, 2	2005-06-14
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma App 20040214806 - Pang, Iok-Hou ; et al.	2004-10-28
Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma App 20040186159 - Hellberg, Mark R. ; et al.	2004-09-23
Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries or trauma App 20040162315 - Hellberg, Mark R. ; et al.	2004-08-19
Use of propentofylline to control intraocular pressure App 20040110776 - Pang, Iok-hou ; et al.	2004-06-10
Use of non-feminizing estrogens as treatment for retinal vascular diseases App 20030050295 - Pang, Iok-Hou	2003-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.